Agenda
Download PDF version of the agenda
| 8:00-8:30 AM | Registration and breakfast |
| 8:30-9:00 AM | Opening Remarks by Glen Gaulton, Ph.D. Executive Vice Dean and Chief Scientific Officer Remarks by
|
Stem Cells and Development. |
|
| 9:00-9:30 AM | Lessons from Development for Beta Cell Programming Kenneth S. Zaret, Ph.D. (Keynote Lecture) Professor of Cell and Developmental Biology Associate Director, Institute for Regenerative Medicine |
| 9:30-10:00 AM | The determinants of pancreatic growth Ben Stanger, M.D., Ph.D. Assistant Professor of Medicine |
| 10:00-10:15 AM | DNase-Chip to Identify Inductive Pathways from Endothelial Cells to Pancreas
Progenitors Deborah Freedman-Cass, Ph.D. * Sr. Research Investigator, Zaret Lab |
| 10:15-10:45 AM | Coffee Break |
Postnatal Beta Cell Growth and Function. |
|
| 10:45-11:15 AM | Proliferation of beta-cells in response to metabolic demand Klaus Kaestner, Ph.D. Professor of Genetics |
| 11:15-11:45 AM | Cell cycle regulation of islet growth Jake Kushner, M.D. Assistant Professor of Pediatrics |
| 11:45-12:15 PM | The Role of Islet-1 in the Endocrine Pancreas Catherine Lee May, Ph.D. Assistant Professor of Pathology and Laboratory Medicine |
| 12:15-1:45 PM | Lunch and Posters |
Transition to Translation. |
|
| 1:45-2:00 PM | Pcif1 regulates Pdx1 protein stability, glucose homeostasis, and the maintenance of beta cell mass Kathryn Claiborn * Graduate Student, Stoffers Lab |
| 2:00-2:15 PM | Genetic Analysis of CREB Function in the Pancreas John Le Lay, Ph.D. * Postdoctoral Researcher, Kaestner Lab |
| 2:15-2:30 PM | The JDRF priorities in Regenerating, Reprogramming and Replacing Beta cell function to treat Type 1 Diabetes Judy M. Hunt Chair, Lay Committee, Juvenile Diabetes Research Foundation |
| 2:30 - 3:00 PM | Prospects for Beta Cell Preservation in Type 1 Diabetes Ali Naji, M.D., Ph.D. Professor of Surgery |
| 3:00-3:30 PM | Functional Beta-Cell Mass in Transplantation and Type 2 Diabetes Michael Rickels, M.D., M.S. Assistant Professor of Medicine |
| 3:30-4:00 PM | GLP-1 receptor antagonism in congenital hyperinsulinism, pathogenetic insights and therapeutic potential Diva D. De León, M.D. Assistant Professor of Pediatrics |
| 4:00-5:00 PM | Reception and Posters |
| *Chosen among abstract submissions | |

